NEMOS
Commercial- Indications
- Epilepsy, Depression, Pain
Company intelligence / Profile preview
cerbomed
Erlangen, Bavaria, Germanyt-vns.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
cerbomed developed a proprietary non-invasive neuromodulation device using transcutaneous vagus nerve stimulation (t-VNS®) targeting the auricular branch of the vagus nerve via the outer ear. The company’s devices have shown safety and feasibility in clinical studies for drug-resistant epilepsy, depression, chronic migraine, pain syndromes, schizophrenia, and tinnitus. t-VNS® has received CE marking for use in depression and epilepsy within the European Union. Clinical results indicate significant reduction in pain perception and promising signals for efficacy across several neuropsychiatric conditions[4][5].
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Cyberonics held a minority investment with rights to global sales/distribution option on NEMOS system for epilepsy treatment as of September 2012
Beyond the preview
Go deeper on cerbomed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cerbomed.